We also investigated whether overexpression of SR (Serine/arginine) protein SRSF1 (previously known as SF2/ASF) drives aberrant AS in MM, thus impacting tumor growth and survival, which provides important biological insights with translational potential. Here, SRSF1 is linked to Miyoshi myopathy.